loading page

Electromagnetic Planning, Guidance and Feedback System Retrofitted to Prostate Biopsy Equipment and Validation
  • +5
  • Alejo Ballester,
  • Christopher Samouce,
  • Tomas Esteverena,
  • Sebastian Sarmiento,
  • Chong Zhao,
  • David Lizdas,
  • Thomas Stringer,
  • Samsun Lampotang
Alejo Ballester
Author Profile
Christopher Samouce
Author Profile
Tomas Esteverena
Author Profile
Sebastian Sarmiento
Author Profile
Chong Zhao
Author Profile
David Lizdas
Author Profile
Thomas Stringer
Author Profile
Samsun Lampotang

Corresponding Author:[email protected]

Author Profile

Abstract

Objective: Design refinement and validation with simulated physical prostates of a planning, guidance, and feedback system for visualizing prostate biopsy in 3D perspective. Methods: A visualized prostate biopsy system (vPBx) using electromagnetic  tracking of a transrectal ultrasound (TRUS) probe, a biopsy device, and a urinary catheter placed inside the patient’s prostate was refined and integrated as a reversible retrofit to a Flex Focus 400 ultrasound machine (BK Medical). The system was verified using simulated physical prostates with 12 0.065 ml (2.5 mm radius) spheres, arranged in a double sextant template, registered to a virtual model of the prostate and used to distinguish hits and misses. Systematic prostate biopsy (sPBx) was performed on simulated prostates using the vPBx as a retrofit to the TRUS machine. Results: The vPBx system enabled an inexperienced user to sample the sPBx template locations with a template deviation below 2.5 mm. Conclusion: An electromagnetic guidance system was refined, retrofitted with a Flex Focus 400 machine and a side-cut biopsy device (Max-Core Disposable Core Biopsy Instrument; Bard) and successfully validated with simulated physical prostates. Significance: If validated with patients, the vPBx system has the potential to reduce prostate biopsy false negatives, which may lead to earlier diagnosis of clinically significant prostate cancer and improved 10-year mortality in high risk prostate cancer patients.
17 Apr 2024Submitted to TechRxiv
23 Apr 2024Published in TechRxiv